Originally Posted by illbethere

Hi. I was a participant in the trials of IPX-066, now called Rytary. It worked really well for me. I was really upset that Impax couldn't find a way for trial participants to continue to receive the limited amount of trial drugs they were able to produce while they fixed their large scale manufacturing process. The multi-year delay is very painful.

I'm hoping that the company will do the right thing this time around and see that the people who took the risks to participate in the trials are given early access to Rytary at reasonable costs.